Zhao Y, Yang J, Xu S, Wang Y, Bo J
Glob Med Genet. 2025; 12(1):100001.
PMID: 39925444
PMC: 11800311.
DOI: 10.1016/j.gmg.2024.100001.
Li Z, Qin C, Zhao B, Li T, Zhao Y, Zhang X
Ther Adv Med Oncol. 2024; 16:17588359241284935.
PMID: 39421679
PMC: 11483845.
DOI: 10.1177/17588359241284935.
Tang M, Zhang Z, Wang P, Zhao F, Miao L, Wang Y
Acta Pharm Sin B. 2024; 14(8):3457-3475.
PMID: 39220884
PMC: 11365446.
DOI: 10.1016/j.apsb.2024.04.034.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
Krawczynska N, Wang Y, Lim K, Das Gupta A, Lenczowski A, Abughazaleh M
bioRxiv. 2024; .
PMID: 39131340
PMC: 11312600.
DOI: 10.1101/2024.08.02.606061.
Phenotypic Plasticity and Cancer: A System Biology Perspective.
Subbalakshmi A, Ramisetty S, Mohanty A, Pareek S, Do D, Shrestha S
J Clin Med. 2024; 13(15).
PMID: 39124569
PMC: 11313222.
DOI: 10.3390/jcm13154302.
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Seyhan A
Int J Mol Sci. 2024; 25(14).
PMID: 39063215
PMC: 11277426.
DOI: 10.3390/ijms25147974.
Fast and efficient isolation of murine circulating tumor cells using screencell technology for pre-clinical analyzes.
Ye F, Wechsler J, Bouzidi A, Uzan G, Naserian S
Sci Rep. 2024; 14(1):15019.
PMID: 38951573
PMC: 11217394.
DOI: 10.1038/s41598-024-66032-x.
Characterisation of circulating tumor-associated and immune cells in patients with advanced-stage non-small cell lung cancer.
Naei V, Ivanova E, Mullally W, OLeary C, Ladwa R, OByrne K
Clin Transl Immunology. 2024; 13(6):e1516.
PMID: 38835954
PMC: 11147668.
DOI: 10.1002/cti2.1516.
N6-methyladenosine modification and post-translational modification of epithelial-mesenchymal transition in colorectal cancer.
Wang Y, Chen Y, Zhao M
Discov Oncol. 2024; 15(1):209.
PMID: 38834851
PMC: 11150216.
DOI: 10.1007/s12672-024-01048-3.
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y
Signal Transduct Target Ther. 2024; 9(1):132.
PMID: 38763973
PMC: 11102923.
DOI: 10.1038/s41392-024-01823-2.
Leukemia circulation kinetics revealed through blood exchange method.
Miller A, Rodriguez F, Langenbucher A, Lin L, Bray C, Duquette S
Commun Biol. 2024; 7(1):483.
PMID: 38643279
PMC: 11032325.
DOI: 10.1038/s42003-024-06181-x.
Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application.
Fan S, Zhou L, Zhang W, Wang D, Tang D
Cell Commun Signal. 2024; 22(1):232.
PMID: 38637851
PMC: 11025274.
DOI: 10.1186/s12964-024-01615-9.
Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells.
Conti S, Venturini V, Canellas-Socias A, Cortina C, Abenza J, Stephan-Otto Attolini C
Nat Commun. 2024; 15(1):3363.
PMID: 38637494
PMC: 11026456.
DOI: 10.1038/s41467-024-47227-2.
Harnessing the power of Microscale AcoustoFluidics: A perspective based on BAW cancer diagnostics.
Harshbarger C
Biomicrofluidics. 2024; 18(1):011304.
PMID: 38434238
PMC: 10907075.
DOI: 10.1063/5.0180158.
Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer.
Wang Z, Feng Y, Wang Y, Ma Y, Liu J, Li D
Thorac Cancer. 2024; 15(8):654-660.
PMID: 38297462
PMC: 10928244.
DOI: 10.1111/1759-7714.15236.
Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M, Gao Z, Gu G, Huang H, Sun A, Zheng C
BMC Cancer. 2023; 23(1):1224.
PMID: 38087278
PMC: 10717563.
DOI: 10.1186/s12885-023-11711-7.
Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry.
Karacosta L, Pancirer D, Preiss J, Benson J, Trope W, Shrager J
Sci Rep. 2023; 13(1):21781.
PMID: 38065965
PMC: 10709404.
DOI: 10.1038/s41598-023-46458-5.
Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers.
Brozos-Vazquez E, Rodriguez-Lopez C, Cortegoso-Mosquera A, Lopez-Landrove S, Muinelo-Romay L, Garcia-Gonzalez J
Front Immunol. 2023; 14:1221113.
PMID: 38022574
PMC: 10654987.
DOI: 10.3389/fimmu.2023.1221113.
The application, safety, and future of immune cell therapies and prognosis in different malignancies.
Einloth K, Gayfield S, McMaster T, Didier A, Dworkin L, Creeden J
Bioimpacts. 2023; 13(6):439-455.
PMID: 38022382
PMC: 10676524.
DOI: 10.34172/bi.2023.27521.